Resources Professional Medical Articles
These articles are found on the internet and I think can be published without breaching copyright of the relevant Journals and medical professionals who publish them. They are offered here on a goodwill not for profit basis only. Please note that there are many more articles in my possession which I would dearly like to offer hear but am to concerned about the laws of copyright to offer.
| # | Web Link | Hits |
|---|---|---|
| 1 |
 Insect sting allergy. A study from 1980 to 2003 of patients who Article showing the improved efficacy of using insect venom rather than insect body parts in immunotherapy |
961 |
| 2 |
Wasp and Bee Sting Deaths in Denmark Mosbech H. Death caused by wasp and bee stings in Denmark 1960–1980. Allergy. 1983;38:195–200. |
1135 |
| 3 |
Hymenoptera sting deaths in the United States Studies of 400 Hymenoptera sting deaths in the United States. J Allergy Clin Immunol. 1973;52:259–264 |
1004 |
| 4 |
Venom skin tests Venom skin tests in insect-allergic and insect-nonallergic populations. J Allergy Clin Immunol. 1985;76:803–807 |
1001 |
| 5 |
Emergency treatment of allergic reactions to hymenoptera stings Emergency treatment of allergic reactions to hymenoptera stings. Clin Exp Allergy. 1991;21:281–288. |
997 |
| 6 |
The value of immunotherapy with venom in children The value of immunotherapy with venom in children with allergy to insect stings. N Engl J Med. 1990;323:1601–1603. |
994 |
| 7 |
Epiemiology of Insect Venom Sensitivity Epidemiology of insect venom sensitivity. JAMA. 1989;262:240–244 |
1039 |
| 8 |
Wasp Sting Mortality in Australia Wasp sting mortality in Australia. Med J Aust. 2000;173:198–200 |
1084 |
| 9 |
The pharaoh and the wasp The pharaoh and the wasp. Allergy Proc. 1989;10:149–151 |
1032 |
| 10 |
controlled trial of immunotherapy in insect hypersensitivity A controlled trial of immunotherapy in insect hypersensitivity. N Engl J Med. 1978;299:157–161 |
1014 |
| 11 |
Guidelines for venom immunotherapy Guidelines for venom immunotherapy. J Allergy Clin Immunol. 1986;77:727–728 |
1067 |
| 12 |
Safety of venom immunotherapy The Hymenoptera venom study. III: Safety of venom immunotherapy. J Allergy Clin Immunol. 1990;86:775–780. |
1012 |
| 13 |
Immunotherapy with yellow jacket venom Immunotherapy with yellow jacket venom. A comparative study including three different extracts, one adsorbed to aluminium hydroxide and two unmodified. Allergy. 1986;41:95–103. |
1077 |
| 14 |
Immunotherapy with Hymenoptera venoms Immunotherapy with Hymenoptera venoms. Position paper of the Working Group on Immunotherapy of the European Academy of Allergy and Clinical Immunology. Allergy. 1987;42:401–413. |
1062 |
| 15 |
Late-onset allergic reactions Late-onset allergic reactions, including serum sickness, after insect stings. J Allergy Clin Immunol. 1989;84:331–337 |
1043 |
| 16 |
Venom immunotherapy Venom immunotherapy: 10 years of experience with administration of single venoms and 50 micrograms maintenance doses. J Allergy Clin Immunol. 1992;89:1189–1195 |
996 |
| 17 |
Duration of venom immunotherapy Duration of venom immunotherapy: relationship to the severity of symptoms of initial insect sting anaphylaxis. J Allergy Clin Immunol. 1993;92:831–836 |
987 |
| 18 |
The sting challenge test in Hymenoptera venom allergy The sting challenge test in Hymenoptera venom allergy. Position paper of the Subcommittee on Insect Venom Allergy of the European Academy of Allergology and Clinical Immunology. Allergy. 1996;51:216–225 |
1022 |
| 19 |
Safety of Hymenoptera venom rush immunotherapy Safety of Hymenoptera venom rush immunotherapy. Allergy. 1997;52:94–96. |
1027 |
| 20 |
Insect venom allergy: diagnosis and treatment Insect venom allergy: diagnosis and treatment. J Allergy Clin Immunol. 1984;73:299–304 |
985 |
| 21 |
Adverse events associated with rush immunotherapy Adverse events associated with rush hymenoptera venom immunotherapy. Med J Aust. 2001;174:227–230. |
1044 |
| 22 |
Outcome of bee and wasp venom immunotherapy (VIT) in a major allergy center in the UK VIT is effective for the therapy of insect venom anaphylaxis, but a proportion of patients continue to have severe reactions despite therapy. The aim of this study was to estimate the incidence of failed responses and to assess the overall effects of VIT on patients' use of emergency medication and quality of life (QOL). Journal of Allergy and Clinical Immunology Volume 113, Issue 2, Supplement 1, February 2004, Page S109 |
904 |
| 23 |
Flow-assisted quantification of in vitro activated basophils in the diagnosis of wasp venom allergy and follow-up of wasp venom immunotherapy Correct identification of the culprit venom is a prerequisite for specific venom immunotherapy (VIT). Despite the efficacy of VIT, issues as how to monitor treatment and when to discontinue maintenance therapy remain to be established. International Society for Analytical Cytology 2006 |
1035 |
| 24 |
Long-term efficacy of venom immunotherapy Objective: To survey sting reaction patterns in patients who had previously discontinued VIT Annals of Allergy, Asthma and Immunology, Volume 100, Number 2, February 2008 , pp. 162-165(4) |
824 |
